TransMedics(TMDX) - 2024 Q1 - Quarterly Results

Exhibit 99.1 TransMedics Reports First Quarter 2024 Financial Results Andover, Mass. – April 30, 2024 – TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended March 31, 2024. Recent Highlights "We are pleased with our first quarter results as we simultaneously drove continued revenue growth, expanded our infrastructure, ...